The Lancet Gastroenterology & Hepatology

We are the world-leading journal dedicated to gastroenterology & hepatology research and review. While a partial measurement of our impact, we are pleased to share our 2024 Impact Factor is 38·6 & our Scopus CiteScore is 51·1. hubs.li/Q03v92hr0 #GITwitter #LiverTwitter

Primary biliary cholangitis is a chronic autoimmune liver disease. A Review in @LancetGastroHep looks at how new treatments and advances can improve personalised care to control liver damage, relieve symptoms & prevent severe liver disease: hubs.li/Q03y9GQ90

Gluten may not actually trigger many irritable bowel syndrome cases newscientist.com/article/248903… via @newscientist #GITwitter #MedTwitter

Our August issue is live! Including research on patient-reported outcomes in #PMR, maternal autoantibodes and fetal congenital heart block, and occupational therapist-led care for hand #OA, plus much more! thelancet.com/journals/lanrh… Cover by Sara Gironi Carnevale

.@WHOEMRO and @LancetGastroHep to host a webinar on ‘Breaking the Barriers to #Hepatitis Elimination in the Eastern Mediterranean Region’. This webinar aims to: 🔵highlight successful hepatitis elimination efforts in Egypt, Pakistan and Morocco, inspiring other countries in the…

New research - Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial thelancet.com/journals/langa… #GITwitter #MedTwitter #IBD

New research - Intraoperative fluorescence angiography with indocyanine green to prevent anastomotic leak in rectal cancer surgery (IntAct): an unblinded randomised controlled trial thelancet.com/journals/langa… #GITwitter #OncTwitter #MedTwitter

New @TheLancet - Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3) thelancet.com/journals/lance… #GITwitter #MedTwitter

New Review - Screening for advanced steatotic liver disease thelancet.com/journals/langa… @AleksanderKrag #LiverTwitter #MedTwitter

New research - Temporal trends in hepatitis C incidence among people tested more than once in Georgia, 2017–23: a nationwide, retrospective cohort thelancet.com/journals/langa… #LiverTwitter #IDTwitter #MedTwitter

NOW ONLINE: the May and June 2025 update on approvals from the European Medicines Agency (EMA), including therapies in oncology, neurology, endocrinology, and ophthalmology, and a review of medicines containing azithromycin thelancet.com/journals/lanep…

Incretin-based therapies are becoming a core component of diabetes care. By linking digestion, metabolism, & cardiovascular function, incretin-based therapies can help reduce morbidity & mortality. Find out more in @TheLancetEndo: hubs.li/Q03wCFJG0

Our August issue is out now at thelancet.com/gastrohep! Content includes Crohn’s disease, MASLD, faecal incontinence, variceal bleeding, food allergies, and more… #GITwitter #MedTwitter #LiverTwitter

New @TheLancetOncol - Total neoadjuvant treatment with short-course radiotherapy followed by sintilimab plus CapOx versus short-course radiotherapy followed by CapOx in patients with locally advanced rectal cancer (SPRING-01) thelancet.com/journals/lanon… #GITwitter #OncTwitter

“The totality of observational studies suggests there is no association between ever versus never use of oral contraceptive and liver cancer risk.” #LiverTwitter #MedTwitter #OncTwitter @OncoAlert

New Comment - Enhancing the safety and quality of paediatric endoscopy in the Netherlands thelancet.com/journals/langa… #GITwitter

New @TheLancetOncol - Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study thelancet.com/journals/lanon… #GITwitter #OncTwitter